IDXX Q4 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+14.3% YoY

Gross Profit

$658M60.3% margin

Operating Income

$316M28.9% margin

Net Income

$248M22.8% margin

EPS (Diluted)

$3.08

QoQ Revenue Growth

-1.3%

Cash Flow

Operating Cash Flow

$352M

Free Cash Flow

$323M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.7B

Stockholders' Equity

$1.6B

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$954M	+14.3%
Gross Profit	$658M	$571M	+15.3%
Operating Income	$316M	$262M	+20.6%
Net Income	$248M	$216M	+14.8%

Revenue Segments

Product

$652M60%

Service

$438M40%

Geographic Segments

UNITED STATES

$675M61%

EMEA

$254M23%

Asia Pacific

$94M8%

Latin America

$45M4%

CANADA

$42M4%